Overview

A Clinical Evaluation of Baofeikang Granule in Combined Pulmonary Fibrosis and Emphysema Treatment

Status:
Unknown status
Trial end date:
2019-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to confirm the efficacy and safety of BaofeiKang Granule in the treatment of Combined Pulmonary Fibrosis and Emphysema patients.
Phase:
Phase 2
Details
Lead Sponsor:
Beijing Municipal Science & Technology Commission
Treatments:
Anti-Asthmatic Agents
Anti-Inflammatory Agents
Expectorants